3SBio Inc. (OTCMKTS:TRSBF – Get Free Report) was the target of a large decline in short interest in September. As of September 30th, there was short interest totaling 8,190,396 shares, a decline of 40.6% from the September 15th total of 13,790,396 shares. Based on an average daily volume of 0 shares, the days-to-cover ratio is currently ∞ days.
3SBio Price Performance
OTCMKTS TRSBF opened at $1.90 on Thursday. 3SBio has a 12-month low of $1.90 and a 12-month high of $4.74. The firm has a 50-day moving average price of $2.12 and a two-hundred day moving average price of $2.36.
About 3SBio
3SBio Inc is a China-based biopharmaceutical company focused on the research, development, manufacturing and commercialization of biologic medicines. Its portfolio primarily serves therapeutic areas including nephrology, oncology, autoimmune diseases and other conditions requiring specialized biologic treatments.
The company’s products include recombinant human erythropoietin products used to treat anemia, recombinant human growth hormone, and thrombopoietin therapies designed to support platelet production.
See Also
- Five stocks we like better than 3SBio
- Tesla Wants to Make Its Own Chips—What Could Go Wrong?
- IREN Limited’s AI Pivot Gains Traction—But Can Its Data Centers Deliver?
- PBF Energy’s Stunning Rally Faces a Critical Test
- Citi Stock Falls Despite Earnings Beat: What Investors Need to Know
Receive News & Ratings for 3SBio Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for 3SBio and related companies with MarketBeat.com's FREE daily email newsletter.
